A novel b-lymphoma cell line and antigen

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/12 (2006.01) A61K 47/48 (2006.01) C07H 21/00 (2006.01) C07K 14/705 (2006.01) C07K 16/30 (2006.01) C07K 17/00 (2006.01) C12N 5/06 (2006.01) C12N 5/08 (2006.01) C12Q 1/00 (2006.01) C12Q 1/68 (2006.01) G01N 33/574 (2006.01) G01N 33/577 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2142989

This invention provides an IL-6 dependent B-cell lymphoma cell line designated DS-1 deposited with the American Type Culture Collection, wherein the cell line is reactive with a monoclonal antibody produced by a hybridoma cell line designated 10D2F6 deposited with the American Type Culture Collection. The invention also provides a purified antigen reactive with a monoclonal antibody produced by 10D2F6. The antigen also exists on DS-1. Also provided is a method of detecting the presence of an antigen-stimulated T-cell comprising detecting the presence of the antigen on a lymphocyte. In addition, the invention pro- vides a method of detecting the presence of a neoplastic cell comprising detecting the presence of the antigen on a cell which is not a normal T-cell.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

A novel b-lymphoma cell line and antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A novel b-lymphoma cell line and antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A novel b-lymphoma cell line and antigen will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2014213

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.